Holoprosencephaly in a fetus with maternal medication of sulfasalazine in early gestation. A case report.
Koyama
N
N
Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.
Komori
S
S
Bessho
T
T
Koyama
K
K
Hiraumi
Y
Y
Maeda
Y
Y
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D017809:Fatal Outcome; D005260:Female; D016142:Holoprosencephaly / Q000139:chemically induced*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D012460:Sulfasalazine